Bellevue Group Ag Portfolio Holdings

Bellevue Group Ag

  • $5.93 Billion
  • Q3 2024

Bellevue Group Ag has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $5.93 Billion distributed in 196 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $343M, Ionis Pharmaceuticals Inc with a value of $315M, Vertex Pharmaceuticals Inc with a value of $266M, Intuitive Surgical Inc with a value of $244M, and Alnylam Pharmaceuticals, Inc. with a value of $223M.

Examining the 13F form we can see an decrease of $42.8M in the current position value, from $5.98B to 5.93B.

Bellevue Group Ag is based out at Kuesnacht, V8

Below you can find more details about Bellevue Group Ag portfolio as well as his latest detailed transactions.

Portfolio value $5.93 Billion
Healthcare: $5.93 Billion
Communication Services: $1.21 Million
Technology: $531,000
Consumer Cyclical: $309,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$125B
$1.91 Million 0.03% of portfolio
36,825
Q3 2024 New
$2.36B
$1.64 Million 0.03% of portfolio
20,595
Q3 2024 Reduced 11.72%
$10.1B
$1.86 Million 0.03% of portfolio
19,233
Q3 2024 Added 38.69%
$5.32B
$1.27 Million 0.02% of portfolio
29,060
Q3 2024 Reduced 59.73%
$4.03B
$1.02 Million 0.02% of portfolio
16,179
Q3 2024 Added 267.7%
$76.2B
$1.39 Million 0.02% of portfolio
22,066
Q1 2024 Reduced 29.96%
$1.01T
$1 Million 0.02% of portfolio
6,000
Q3 2022 Added 1,900.0%
$82.8B
$1.03 Million 0.02% of portfolio
5,284
Q3 2024 Added 79.67%
$3.81B
$1.4 Million 0.02% of portfolio
64,094
Q3 2024 New
$15.5B
$934,000 0.02% of portfolio
5,625
Q3 2024 Added 3.9%
$19B
$1.28 Million 0.02% of portfolio
70,821
Q3 2024 Reduced 54.24%
$5.25B
$1.37 Million 0.02% of portfolio
11,981
Q3 2024 Reduced 15.69%
$1.66B
$1.12 Million 0.02% of portfolio
95,924
Q1 2024 Added 5.16%
$27.5B
$1.04 Million 0.02% of portfolio
8,721
Q3 2024 New
$3.34B
$822,000 0.01% of portfolio
15,700
Q3 2024 Added 20.77%
$4.16B
$517,000 0.01% of portfolio
25,900
Q3 2024 Reduced 16.18%
$16.2B
$456,000 0.01% of portfolio
39,283
Q3 2024 Added 48.06%
$121B
$871,000 0.01% of portfolio
15,109
Q3 2024 New
$1.27B
$635,000 0.01% of portfolio
76,414
Q3 2024 Added 21.76%
$3.31B
$457,000 0.01% of portfolio
15,700
Q3 2024 New
$22.7B
$510,000 0.01% of portfolio
2,634
Q3 2024 Reduced 55.37%
$3.96B
$334,000 0.01% of portfolio
4,000
Q3 2024 New
$3.38B
$549,000 0.01% of portfolio
19,046
Q3 2024 Reduced 95.71%
$1.17B
$433,000 0.01% of portfolio
31,000
Q3 2024 New
$610M
$367,000 0.01% of portfolio
39,500
Q3 2024 Added 125.71%
$2.28B
$554,000 0.01% of portfolio
12,346
Q3 2024 Reduced 18.49%
$3B
$469,000 0.01% of portfolio
24,015
Q3 2024 Reduced 97.91%
$2.09B
$399,000 0.01% of portfolio
8,000
Q3 2024 Reduced 18.37%
$97.5B
$309,000 0.01% of portfolio
3,500
Q2 2024 New
$4.62B
$577,000 0.01% of portfolio
10,941
Q3 2024 Reduced 34.32%
$4.89B
$869,000 0.01% of portfolio
4,779
Q3 2024 Added 13.84%
$2.01B
$221,000 0.0% of portfolio
4,400
Q1 2024 New
$3.31B
$222,000 0.0% of portfolio
4,000
Q2 2024 New
Molecular Templates Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 24.28%
Ge Healthcare Technologies I
-
$0 0.0% of portfolio
-
Q3 2024 Added 2.1%
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 5.71%
$27.4B
$61,000 0.0% of portfolio
41
Q3 2024 Added 2.5%
$3.11T
$83,000 0.0% of portfolio
194
Q3 2024 Added 8.38%
$39.6B
$114,000 0.0% of portfolio
769
Q3 2024 Added 9.23%
$1.29B
$228,000 0.0% of portfolio
7,200
Q3 2024 Added 26.32%
$5.94B
$233,000 0.0% of portfolio
1,100
Q2 2024 Added 3.77%
Waystar Hldg Corp
-
$0 0.0% of portfolio
-
Q3 2024 Added 0.13%
Labcorp Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 8.42%
$40.3B
$184,000 0.0% of portfolio
1,050
Q2 2024 Reduced 62.5%
$722M
$265,000 0.0% of portfolio
13,600
Q3 2024 Added 36.0%
$176B
$72,000 0.0% of portfolio
427
Q3 2024 Added 9.21%
Cooper Cos Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
$1.07B
$171,000 0.0% of portfolio
9,300
Q3 2024 Reduced 52.79%
$518B
$106,000 0.0% of portfolio
624
Q3 2024 Added 9.28%

Summary

  • Portfolio
  • No. of Stocks 196
  • Current Value $5.93 Billion
  • Prior Value $5.98 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 11 stocks
  • Additional Purchases 57 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 71 stocks
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email